Accessibility Menu
 
HCA Healthcare logo

HCA Healthcare

(NYSE) HCA

Current Price$474.88
Market Cap$105.83B
Since IPO (2011)+1,946%
5 Year+165%
1 Year+38%
1 Month-11%

HCA Healthcare Financials at a Glance

Market Cap

$105.83B

Revenue (TTM)

$75.60B

Net Income (TTM)

$6.78B

EPS (TTM)

$28.38

P/E Ratio

16.67

Dividend

$2.94

Beta (Volatility)

0.72 (Low)

Price

$474.88

Volume

14,984

Open

$474.55

Previous Close

$473.24

Daily Range

$470.63 - $475.45

52-Week Range

$314.43 - $556.52

HCA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HCA Healthcare

Industry

Healthcare Providers and Services

Employees

320,000

CEO

Samuel N. Hazen, MBA

Headquarters

Nashville, TN 37203, US

HCA Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

16%

Net Income Margin

9%

Return on Equity

0%

Return on Capital

27%

Return on Assets

11%

Earnings Yield

6.00%

Dividend Yield

0.01%

Payout Ratio

10.01%

Stock Overview

Market Cap

$105.83B

Shares Outstanding

223.62M

Volume

14.98K

Short Interest

0.00%

Avg. Volume

1.13M

Financials (TTM)

Gross Profit

$31.37B

Operating Income

$11.96B

EBITDA

$15.60B

Operating Cash Flow

$12.64B

Capital Expenditure

$4.94B

Free Cash Flow

$7.69B

Cash & ST Invst.

$1.04B

Total Debt

$50.20B

HCA Healthcare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$19.51B

+6.7%

Gross Profit

$8.18B

+7.9%

Gross Margin

41.90%

N/A

Market Cap

$105.83B

N/A

Market Cap/Employee

$330.71K

N/A

Employees

320,000

N/A

Net Income

$1.88B

+30.6%

EBITDA

$4.16B

+18.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$49.16B

-13.5%

Accounts Receivable

$10.87B

+1.1%

Inventory

$1.65B

-4.9%

Long Term Debt

$43.46B

+8.1%

Short Term Debt

$6.74B

+33.7%

Return on Assets

11.17%

N/A

Return on Invested Capital

26.97%

N/A

Free Cash Flow

$870.00M

-31.7%

Operating Cash Flow

$2.36B

-7.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MCKMcKesson Corporation
$875.34+1.15%
MDTMedtronic plc
$85.97-0.78%
GSKGSK plc
$56.32+2.05%
VRTXVertex Pharmaceuticals Incorporated
$448.77+0.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.62+3.27%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.73+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.33-0.03%

Questions About HCA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.